Evidence map›Paper›PMID 16595371›Full record

ArticleJournal of neurovirology2006

Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease.

Lynn M Wachtman, Patrick M Tarwater, Suzanne E Queen, Robert J Adams, Joseph L Mankowski

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lynn M WachtmanDepartment of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.
Patrick M Tarwater
Suzanne E Queen
Robert J Adams
Joseph L Mankowski
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Immunophilin ligands for HIV dementia and neuropathyP01MH070056 · NIMH · JOHNS HOPKINS UNIVERSITY · PI NATH, AVINDRA · 2003 to 2006
$5.6M
Neuroprotective Effects of Minocycline in Lentiviral InfR01MH069116 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2004 to 2008
$2.9M
Antiretroviral Therapy and SIV EncephalitisR01NS044815 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2002 to 2005
$2.0M
NCRR NIH HHS RR07002NIMH NIH HHS MH069116NIMH NIH HHS MH 070056NINDS NIH HHS NS 44815
6 · The paper itself

Abstract

As the prevalence of human immunodeficiency virus (HIV)-induced central nervous system (CNS) disease has increased with antiretroviral treatment, there is a critical need for identifying biomarkers that predict HIV CNS disease. To identify novel hematologic markers that precede and predict CNS disease, the authors examined longitudinal hematology data from 47 simian immunodeficiency virus (SIV)-infected macaques. This study demonstrated that the magnitude of decline in circulating platelet counts beginning at day 28 post infection, during asymptomatic SIV infection, predicted the eventual development of SIV encephalitis. Univariate analysis performed on platelet values obtained day 56 post inoculation demonstrated that SIV-infected macaques with the greatest decline in platelet numbers were 18 times more likely to develop SIV CNS disease than SIV-infected animals with minimal to no decline in circulating platelet counts. Decline in platelet number was a more robust marker than decline in hemoglobin levels, a previously identified marker of HIV CNS disease. The identification of an association between decline in platelets and the development of encephalitis demonstrates that monitoring platelet decline in HIV-infected individuals may serve as a predictive marker for clinical progression to HIV-induced CNS disease. Identifying those HIV-infected individuals at risk for CNS disease during asymptomatic stages of infection would promote early interventive, neuroprotective therapy to prevent neuronal damage and loss.

Indexed as

Platelet CountSimian Immunodeficiency VirusAnimalsBiomarkersCentral Nervous System DiseasesDisease Models, AnimalMacacaSimian Acquired Immunodeficiency SyndromeBiomarkers

Identifiers

PMID16595371
OpenAlexW2097412657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.